“The third quarter of 2024 drew consistent attention to our pivotal-staged clinical asset, EB613, the first oral PTH(1-34) tablet treatment dedicated to post-menopausal women with high risk ...

Women with symptoms of menopause should be offered hormone replacement therapy ( HRT) as the first treatment, a health ...

Hormone replacement therapy (HRT) should be the first treatment offered to women with symptoms of the menopause, a health watchdog has said in strengthened guidance.

Strengthened NHS guidance stresses that HRT should be the ‘first-line treatment’ for hot flushes, insomnia and low mood ...

The National Institute for Health and Care Excellence (Nice) has issued new guidance that states women should be offered hormone replacement therapy (HRT) as the "first-choice" treatment for menopause ...

A breakthrough in Taiwan could mean earlier diagnosis and personalized treatment for those suffering from arthritis and ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

Two "key" genes have been identified by scientists linking the painful condition and the bone disease osteoporosis.

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...